$120.54
-1.17-0.96%
Last update: Oct 20, 11:49 AM
$121.71
N/A
Encompass Health Corp
EHCNYSE
Encompass Health (EHC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Encompass Health (EHC) last issued guidance on August 5, 2026 for fiscal year 2026. The company guided earnings per share in the range of $6.02 - $6.25, compared to a consensus EPS estimate of $6. Encompass Health also guided revenue in the range of $6.41B - $6.49B for the period.
Compared to prior guidance, Encompass Health raised its EPS outlook from a previous range of $5.89 - $6.11. On the revenue side, the company maintained its revenue forecast from a prior range of $6.38B - $6.47B.
Encompass Health has issued 20 guidance updates between October 26, 2022 and August 5, 2026. During this period, the company raised its outlook 14 times, reflecting management's growing confidence in business performance.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.48 | $1.50 | $1.30 | $1.19 |
| Actual | $1.55 | $1.60 | $1.46 | $1.23 |
| Surprise | +4.73% | +6.67% | +12.3% | +3.36% |
| Revenue | ||||
| Estimate | $1.57B | $1.57B | $1.54B | $1.48B |
| Actual | $1.60B | $1.59B | $1.54B | $1.48B |
| Surprise | +1.59% | +1.14% | +0.34% | -0.16% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.36 | $1.61 | $1.70 | $1.69 |
| Revenue | ||||
| Consensus | $1.60B | $1.67B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $1.55 | $1.48 | 4.73 % |
| Q1 | Apr 30, 2026 | $1.60 | $1.50 | 6.67 % |
| Q4 | Feb 5, 2026 | $1.46 | $1.30 | 12.3 % |
| Q3 | Oct 29, 2025 | $1.23 | $1.19 | 3.36 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $1.60B | $1.57B | 1.59 % |
| Q1 | Apr 30, 2026 | $1.59B | $1.57B | 1.14 % |
| Q4 | Feb 5, 2026 | $1.55B | $1.54B | 0.34 % |
| Q3 | Oct 29, 2025 | $1.48B | $1.48B | -0.16 % |
